Based on the literature, as well as on the experience in our own research group [19-21], we designed the present study to assess whether ER- expression in tumor tissue correlates with methylated status of the ESR1 in serum i.e. a mechanism of gene silencing that can explain, at least in part, the lack of hormone therapy efficacy in breast cancer. Here, ESR1 is linked to breast cancer.